Literature DB >> 6377565

Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin.

D C Triantaphyllopoulos.   

Abstract

Twenty-one rabbits were infused with 20 micrograms/kg/hr of E. coli endotoxin for 6 hr. Eight of the animals were preinjected immediately before the infusion of endotoxin, with a bolus dose of human AT III calculated to increase the antithrombin content of the plasma by about 4 units/ml. All eight animals which were preinjected with AT III survived, while 5 of the 13 control rabbits infused with endotoxin alone died. The changes in coagulation parameters from the baseline values, between the 8 control rabbits which survived and the 8 animals which were preinjected with AT III were compared. The concentration of the preinjected human AT III declined significantly faster (P: less than 0.01) than that of the native rabbit AT III. AT III prevented the decline of F.XII throughout the infusion of the endotoxin. However, the decline in F.V, fibrinogen, prothrombin and platelets was not affected (P: greater than 0.5) by the injection of AT III.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377565

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis.

Authors:  H Yamaguchi; H Weidenbach; H Lührs; M M Lerch; G Dickneite; G Adler
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

2.  Use of antithrombin III in critical patients.

Authors:  J M Díaz-Cremades; R Lorenzo; M Sánchez; M J Moreno; M J Alsar; J M Bosch; L Fajardo; D González; D Guerrero
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

3.  Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology.

Authors:  J L Vincent
Journal:  Crit Care       Date:  2001       Impact factor: 9.097

Review 4.  Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.

Authors:  Toshiaki Iba; Daizoh Saitoh
Journal:  J Intensive Care       Date:  2014-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.